SO
55
13
COST
54
4
SE
65
5
ZTS
34
5
CHRW
57
-3
RCL
64
3
BLK
46
2
COF
47
-2
CNX
49
7
UA
51
-5
ADI
62
5
LYB
34
-2
EQT
56
2
ADP
66
4
GIS
34
2
SCHW
42
2
IBM
48
-2
CME
52
2
NOC
45
2
ALL
43
6
SO
55
13
COST
54
4
SE
65
5
ZTS
34
5
CHRW
57
-3
RCL
64
3
BLK
46
2
COF
47
-2
CNX
49
7
UA
51
-5
ADI
62
5
LYB
34
-2
EQT
56
2
ADP
66
4
GIS
34
2
SCHW
42
2
IBM
48
-2
CME
52
2
NOC
45
2
ALL
43
6
Financhill
Back

ICF International Vs. Janux Therapeutics Industry Stock Comparison

Sell
21

ICFI
ICF International

Last Price:
$119.11
Seasonality Move:
2.04%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
21
ICF International (ICFI) is a Sell

Is ICF International a Buy, Sell or Hold?

  • The current ICF International [ICFI] share price is $119.14. The Score for ICFI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • ICFI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ICFI Stock Price Chart

What is ICF International's stock price today?

  • The ICF International share price today is $119.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ICFI is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

ICFI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.84 Sell
Relative Strength Index (14 RSI): 35.72 Sell
Chaikin Money Flow: 129548 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (117.53 - 129.99) Sell
Bollinger Bands (100): (132.93 - 172.01) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

ICFI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 117.88 Buy
20-day SMA: 121.36 Sell
50-day SMA: 139.06 Sell
200-day SMA: 148.5 Sell
8-day EMA: 118.2 Buy
20-day EMA: 122.42 Sell
50-day EMA: 134.43 Sell
200-day EMA: 145.1 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

ICF International Earnings Growth & ICFI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $0.78 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

ICF International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):